The library will be closed between August 11, 2025, and August 17, 2025. During this period, it will be possible to upload publications, but all other services will be suspended.
Tao, L.,
Yu, W.,
Liu, Z.,
Zhao, D.,
Lin, S.,
Vargáné Szalóki, D.,
Kicsák, M.,
Kurtán, T.,
Zhang, H. Y.:
JE-133 suppresses LPS-induced neuroinflammation associated with the regulation of JAK/STAT and Nrf2 signaling pathways.
ACS Chem. Neurosci. 15 (2), 258-267, 2024.
Mándi, A.,
Rimóczi, A.,
Vasas, A.,
Hohmann, J.,
Swamy, M. M. M.,
Monde, K.,
Barta, R. A.,
Kicsák, M.,
Komáromi, I.,
Fehér, K.,
Kurtán, T.:
Testing the Simplified Molecular Dynamics Approach to Improve the Reproduction of ECD Spectra and Monitor Aggregation.
Int. J. Mol. Sci. 25 (12), 1-18, (article identifier: 6453), 2024.
Elnaggar, M. S.,
Elissawy, A. M.,
Youssef, F. S.,
Kicsák, M.,
Kurtán, T.,
Singab, A.,
Kalscheuer, R.:
Austalide derivative from marine-derived Aspergillus sp. and evaluation of its cytotoxic and ADME/TOPKAT properties.
RSC Adv. 13 (24), 16480-16487, 2023.
Szűcs, Z.,
Ostorházi, E.,
Kicsák, M.,
Nagy, L.,
Borbás, A.,
Herczegh, P.:
New semisynthetic teicoplanin derivatives have comparable in vitro activity to that of oritavancin against clinical isolates of VRE.
J. Antibiot. 72 (7), 524-534, 2019.
Bereczki, I.,
Kicsák, M.,
Dobray, L.,
Borbás, A.,
Batta, G.,
Kéki, S.,
Nemes Nikodém, É.,
Ostorházi, E.,
Rozgonyi, F.,
Vanderlinden, E.,
Naesens, L.,
Herczegh, P.:
Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: synthesis and antiviral studies.
Bioorg. Med. Chem. Lett. 24 (15), 3251-3254, 2014.
